 |
市场调查报告书
商品编码
1629606
生技药品市场、副产品、药物分类、给药途径、购买方式、通路和地区。Biologics Market, By Product, By Drug Classification, By Route of Administration, By Mode of Purchase, By Distribution Channel,By Geography . |
||||||
全球生技药品市场预计到2024年将达到5.221亿美元，预计到2031年将达到10.442亿美元，2024年至2031年的复合年增长率为10.4%。
| 报告范围 | 报告详情 | ||
|---|---|---|---|
| 基准年 | 2023年 | 2024年市场规模 | 5.221 亿美元 |
| 实际资料 | 2019-2023 | 预测期 | 2024-2031 |
| 预测 2024-2031 年复合年增长率： | 10.40% | 2031年价值预测 | 10.442 亿美元 |
生技药品是指由活生物体製成的用于预防、治疗或治癒人类疾病的药物。这包括疫苗、血液成分、过敏原、体细胞、基因疗法、组织、重组治疗性蛋白质等。全球慢性病的盛行率正在增加，加上老年人口不断增加，更容易患各种疾病，这可能会推动对生技药品的需求。生物技术的快速创新和进步使得新型生技药品的开发成为可能，其安全性、有效性和作用特异性得到提升。这扩大了多种危及生命的疾病的治疗选择，包括癌症、风湿病和自体免疫疾病。监管部门的核准和生技药品商业化的增加可能会推动市场成长。
市场动态
全球生技药品市场的成长是由糖尿病、癌症和心血管疾病等慢性病的全球流行以及生技药品研发医疗保健支出的增加所推动的。对蛋白质药物的需求不断增长、先进生技药品的快速核准以及新型生技药品候选产品的强大管道也正在推动市场成长。生物加工和品质分析的持续技术进步使得高产量生产平台的开发成为可能，这些平台有利于在商业规模上经济高效地製造生技药品。然而，建立生物製造设施所需的大量资本投资、严格的监管标准以及生物分子的复杂性给生物相似药的开发带来了挑战。亚太和拉丁美洲等新兴市场为相关人员探索新市场和抵销市场限制提供了有利可图的机会。
本研究的主要特点
本报告对全球生技药品市场进行了详细分析，并提供了以2023年为基准年的预测期（2024-2031）的市场规模和年复合成长率（CAGR%）。
它还揭示了各个细分市场的潜在商机，并说明了该市场有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
根据公司亮点、产品系列、主要亮点、绩效和策略等参数对全球生技药品市场的主要企业进行了分析。
本研究涵盖的主要企业包括罗氏有限公司、艾伯维公司、安进公司、强生服务公司、默克公司、辉瑞公司、赛诺菲公司、吉利德科学公司.、诺华公司、百时美施贵宝公司、再生元製药公司、武田製药有限公司、百健公司、礼来公司和公司、Celltrion Healthcare Co., Ltd.等
该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
全球生技药品市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
透过分析全球生技药品市场时所使用的各种策略矩阵，将有助于相关人员做出决策。
目录
第一章 研究目的与前提
- 研究目的
- 先决条件
- 简称
第二章 市场展望
- 报告说明
- 市场定义和范围
- 执行摘要
第三章 市场动态、法规与趋势分析
- 市场动态
- 影响分析
- 主要进展
- 监管场景
- 产品发布/核准
- PEST分析
- 波特分析
- 併购场景
- 产业动态
第四章 全球生技药品市场（依产品），2019-2031
- 单株抗体
- 疫苗
- 重组荷尔蒙/蛋白质
- 基于细胞的生技药品
- 基于基因的生技药品
- 其他的
第五章全球生技药品市场，依药物分类，2019-2031
- 原药
- 学名药
第六章 全球生技药品市场，依管理途径，2019-2031
- 口服
- 胃肠外的
- 其他路线
第七章 全球生技药品市场，依采购类型，2019-2031
- 处方药
- 非处方药
第 8 章全球生技药品市场，依通路划分，2019-2031 年
- 医院药房
- 零售药房
- 网路药房
第九章全球生技药品市场，按地区，2019-2031
- 北美洲
- 拉丁美洲
- 欧洲
- 亚太地区
- 中东
- 非洲
第10章竞争格局
- Hoffmann-La Roche Ltd.
- AbbVie Inc.
- Amgen Inc.
- Johnson & Johnson Services, Inc.
- Merck & Co., Inc.
- Pfizer Inc.
- Sanofi SA
- Gilead Sciences, Inc.
- Novartis AG
- Bristol-Myers Squibb Company
- Regeneron Pharmaceuticals, Inc.
- Takeda Pharmaceutical Company Limited
- Biogen Inc.
- Eli Lilly and Company
- Celltrion Healthcare Co., Ltd.
第十一章 参考文献与调查方法
- 参考
- 调查方法
- 关于出版商
Global biologics market is estimated to be valued at USD 522.1 Mn in 2024 and is expected to reach USD 1,044.2 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 10.4% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 522.1 Mn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 10.40% | 2031 Value Projection: | US$ 1,044.2 Mn |
Biologics refers to medicines created from living organisms that are used to prevent, treat, and cure human diseases. These include vaccines, blood components, allergenics, somatic cells, gene therapies, tissues, and recombinant therapeutic proteins. Increasing prevalence of chronic diseases worldwide coupled with rising elderly population prone to various illnesses can boost demand for biologics. Rapid innovations and advancements in biotechnology have enabled development of novel biologic agents with improved safety, efficacy and specificity of action. This has expanded treatment options for several life-threatening conditions such as cancer, rheumatic disorders, and autoimmune diseases. Growing regulatory approvals and commercialization of biologics can drive the market growth.
Market Dynamics
Global biologics market growth is driven by growing prevalence of chronic diseases worldwide such as diabetes, cancer, cardiovascular diseases along with rising healthcare expenditure on biopharmaceutical R&D. Increasing demand for protein-based drugs, rapid approvals of advanced biologics and strong pipeline of novel biologic candidates can also drive the market growth. Constant technological advancements in bioprocessing and quality analytics enables development of high-yield production platforms conducive for cost-effective manufacturing of biologics at commercial scale. However, factors such as high capital investment needs for setting up bio-manufacturing facilities, stringent regulatory norms, and complexity of biological molecules poses challenges in biosimilar development. Emerging markets across developing regions such as Asia Pacific and Latin America offer lucrative opportunities for stakeholders to tap into new geographic territories and offset restraint impact.
Key Features of the Study
This report provides in-depth analysis of the global biologics market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global biologics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd., AbbVie Inc., Amgen Inc., Johnson & Johnson Services, Inc., Merck & Co., Inc., Pfizer Inc., Sanofi S.A., Gilead Sciences, Inc., Novartis AG, Bristol-Myers Squibb Company, Regeneron Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited, Biogen Inc., Eli Lilly and Company, and Celltrion Healthcare Co., Ltd.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global biologics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biologics market
Market Segmentation
- By Product Insights (Revenue, USD Mn, 2019 - 2031)
- Monoclonal Antibodies
- Vaccines
- Recombinant Hormones/Proteins
- Cellular-based Biologics
- Gene-based Biologics
- Others
- By Drug Classification Insights (Revenue, USD Mn, 2019 - 2031)
- Branded Drugs
- Generic Drugs
- By Route of Administration Insights (Revenue, USD Mn, 2019 - 2031)
- Oral
- Parenteral
- Other Routes
- By Mode of Purchase Insights (Revenue, USD Mn, 2019 - 2031)
- Prescription-Based Drugs
- Over-The-Counter Drugs
- By Distribution Channel Insights (Revenue, USD Mn, 2019 - 2031)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Mn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- F. Hoffmann-La Roche Ltd.
- AbbVie Inc.
- Amgen Inc.
- Johnson & Johnson Services, Inc.
- Merck & Co., Inc.
- Pfizer Inc.
- Sanofi S.A.
- Gilead Sciences, Inc.
- Novartis AG
- Bristol-Myers Squibb Company
- Regeneron Pharmaceuticals, Inc.
- Takeda Pharmaceutical Company Limited
- Biogen Inc.
- Eli Lilly and Company
- Celltrion Healthcare Co., Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Biologics Market, By Product
- Global Biologics Market, By Drug Classification
- Global Biologics Market, By Route of Administration
- Global Biologics Market, By Mode of Purchase
- Global Biologics Market, By Distribution Channel
- Global Biologics Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Biologics Market, By Product, 2019-2031, (USD Mn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Monoclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Recombinant Hormones/Proteins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Cellular-based Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Gene-based Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
5. Global Biologics Market, By Drug Classification, 2019-2031, (USD Mn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Branded Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Generic Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
6. Global Biologics Market, By Route of Administration, 2019-2031, (USD Mn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Other Routes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
7. Global Biologics Market, By Mode of Purchase, 2019-2031, (USD Mn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Prescription-Based Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Over-The-Counter Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
8. Global Biologics Market, By Distribution Channel, 2019-2031, (USD Mn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
9. Global Biologics Market, By Region, 2019 - 2031, (USD Mn)
- Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Drug Classification, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Mode of Purchase, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Drug Classification, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Mode of Purchase, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Drug Classification, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Mode of Purchase, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Drug Classification, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Mode of Purchase, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Drug Classification, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Mode of Purchase, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Drug Classification, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Mode of Purchase, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, (USD Mn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson Services, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co., Inc.
- Pfizer Inc.
- Sanofi S.A.
- Gilead Sciences, Inc.
- Novartis AG
- Bristol-Myers Squibb Company
- Regeneron Pharmaceuticals, Inc.
- Takeda Pharmaceutical Company Limited
- Biogen Inc.
- Eli Lilly and Company
- Celltrion Healthcare Co., Ltd.
11. References and Research Methodology
- References
- Research Methodology
- About us
癌症生物治疗市场 - 全球产业规模、份额、趋势、机会和预测，按产品、配销通路、地区和竞争细分，2020-2030 年
生物製剂合约开发市场，按服务类型、生物製剂类型、最终用户、国家和地区划分 - 2025 年至 2032 年全球行业分析、市场规模、市场份额和预测
注射用生物製药市场 - 技术，治疗，市场，策略，预测
癌症生物製剂市场 - 全球产业规模、份额、趋势、机会和预测，按产品、应用、最终用户、地区和竞争细分，2020-2030F
生物处理技术市场 - 全球产业规模、份额、趋势、机会和预测，按处理、应用、地区和竞争细分，2020-2030F
癌症生物治疗市场规模、份额、成长分析，按产品、按癌症类型、按阶段、按给药途径、按分销管道、按最终用户、按地区 - 行业预测，2025 年至 2032 年
生技药品契约製造市场规模、份额、趋势分析报告：按产品、适应症、地区、细分市场预测，2025-2030 年
2024-2032 年日本生物製品市场报告（按来源、产品、疾病、製造和地区）
生物製品灌装和成品製造市场：按初级包装容器类型、按生产的生物製品类型、按业务规模、按治疗领域、按最终用户、按输入公司类型、按地区：到2035 年的行业趋势以及全球预测
生技药品市场：按来源、产品、适应症和最终用户分类 - 2025-2030 年全球预测